BRAF and metastatic malignant neoplasm in the lymph nodes: Various associations have been reported between the presence of BRAF V600E mutation and demographic data or risk factors, such as tumor size, multifocality, lymph node metastasis, vascular invasion, extra-thyroid extension, and advanced stage of tumor node metastasis [6,7,8,9,10].